Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Ychou

Showing results (31-40 of 103) with videos related to

Pageof 11
Sort By:
La Revue De Medecine Interne|November 25, 1998
[Carcinoma of unknown primary site. Apropos of 100 patients treated at the Montpellier regional center of cancer prevention]S Culine, L Gazagne, M Ychou, et al.
Journal of Chemotherapy (Florence, Italy)|June 23, 2010
Clinical impact of intesified 5-Fluorouracil-based chemotherapy using a prospective pharmacokinetically-guided dosing approach: comparative study in elderly and non-elderly patients with metastatic colorectal cancerJ Duffour, L Roca, F Bressolle, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Stomach adenocarcinomas: comparison between CA 19-9 and carcinoembryonic antigen for the diagnosis of recurrences after surgical treatment]M Ychou, T Tuszinski, J P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumorsM Ychou, T Conroy, J F Seitz, et al.
Cancer|April 15, 1993
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patientsP Ruszniewski, P Rougier, A Roche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panelB Nordlinger, E Van Cutsem, T Gruenberger, et al.
Cancer Research|October 15, 1996
Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alphaB Robert, J P Mach, J C Mani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1994
Detection of lymph node metastases in lung cancer: comparison of 131I-anti-CEA-anti-CA 19-9 immunoscintigraphy versus computed tomographyG Boilleau, J L Pujol, M Ychou, et al.
British Journal of Cancer|July 29, 1999
Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental modelA Leconte, V Garambois, M Ychou, et al.
Anticancer Research|January 30, 2003
Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancerJ Duffour, S Gourgou, J F Seitz, et al.
Pageof 11

Showing results (31-40 of 103) with videos related to

Sort By:
Pageof 11
La Revue De Medecine Interne|November 25, 1998
[Carcinoma of unknown primary site. Apropos of 100 patients treated at the Montpellier regional center of cancer prevention]S Culine, L Gazagne, M Ychou, et al.
Journal of Chemotherapy (Florence, Italy)|June 23, 2010
Clinical impact of intesified 5-Fluorouracil-based chemotherapy using a prospective pharmacokinetically-guided dosing approach: comparative study in elderly and non-elderly patients with metastatic colorectal cancerJ Duffour, L Roca, F Bressolle, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1992
[Stomach adenocarcinomas: comparison between CA 19-9 and carcinoembryonic antigen for the diagnosis of recurrences after surgical treatment]M Ychou, T Tuszinski, J P Pignon, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 25, 2003
An open phase I study assessing the feasibility of the triple combination: oxaliplatin plus irinotecan plus leucovorin/ 5-fluorouracil every 2 weeks in patients with advanced solid tumorsM Ychou, T Conroy, J F Seitz, et al.
Cancer|April 15, 1993
Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patientsP Ruszniewski, P Rougier, A Roche, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 21, 2009
Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panelB Nordlinger, E Van Cutsem, T Gruenberger, et al.
Cancer Research|October 15, 1996
Cytokine targeting in tumors using a bispecific antibody directed against carcinoembryonic antigen and tumor necrosis factor alphaB Robert, J P Mach, J C Mani, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 1994
Detection of lymph node metastases in lung cancer: comparison of 131I-anti-CEA-anti-CA 19-9 immunoscintigraphy versus computed tomographyG Boilleau, J L Pujol, M Ychou, et al.
British Journal of Cancer|July 29, 1999
Involvement of circulating CEA in liver metastases from colorectal cancers re-examined in a new experimental modelA Leconte, V Garambois, M Ychou, et al.
Anticancer Research|January 30, 2003
Efficacy of prophylactic anti-diarrhoeal treatment in patients receiving Campto for advanced colorectal cancerJ Duffour, S Gourgou, J F Seitz, et al.
Pageof 11